Literature DB >> 29952495

Breast cancer: basics, screening, diagnostics and treatment.

Bernhard Wörmann.   

Abstract

Breast cancer is by far the most common malignancy in women. The median age is 64 years. Stage at diagnosis and biological features determine the prognosis. Patients with early breast cancer, with locally advanced disease and with locoregional relapse can be cured. Modern treatment is multimodal. It includes surgery, radiation and drug therapy. Patients with metastatic disease are treated with palliative intent. Aims are alleviation of symptoms and prolongation of survival. Breast cancer specific mortality has continually decreased in the past 10 years. Five year survival rate is 87% in Germany. Patients with early breast cancer have an even higher chance of cure.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 29952495

Source DB:  PubMed          Journal:  Med Monatsschr Pharm        ISSN: 0342-9601


  35 in total

Review 1.  Role of Exosomes for Delivery of Chemotherapeutic Drugs.

Authors:  Aragaw Gebeyehu; Nagavendra Kommineni; David G Meckes; Mandip Singh Sachdeva
Journal:  Crit Rev Ther Drug Carrier Syst       Date:  2021       Impact factor: 4.889

2.  STAT1 mediated long non-coding RNA LINC00504 influences radio-sensitivity of breast cancer via binding to TAF15 and stabilizing CPEB2 expression.

Authors:  Jinchun Feng; Yan Li; Liping Zhu; Qian Zhao; Dan Li; Yuxiang Li; Tao Wu
Journal:  Cancer Biol Ther       Date:  2021-12-15       Impact factor: 4.742

3.  Exosomal microRNA-551b-3p from bone marrow-derived mesenchymal stromal cells inhibits breast cancer progression via regulating TRIM31/Akt signaling.

Authors:  Ziang Yang; Bei Xu; Sheng Wu; Weige Yang; Rongkui Luo; Shengkai Geng; Zhaochen Xin; Wen Jin; Xiong Shen; Xixi Gu; Hongwei Zhang; Hong Wang
Journal:  Hum Cell       Date:  2022-08-09       Impact factor: 4.374

4.  Knockdown of circ-ADAM9 inhibits malignant phenotype and enhances radiosensitivity in breast cancer cells via acting as a sponge for miR-383-5p.

Authors:  Penghui Song; Jianjun Wu; Jianbing Chen; Fang Wang; Jingmei Chen; Guanyu Wang
Journal:  Strahlenther Onkol       Date:  2022-10-07       Impact factor: 4.033

5.  Expression and prognostic value of ratios of platelet lymphocyte, neutrophil lymphocyte and lymphocyte monocyte in breast cancer patients.

Authors:  Deba Song; Xiaoxu Li; Xiaojian Zhang
Journal:  Am J Transl Res       Date:  2022-05-15       Impact factor: 3.940

Review 6.  Tumor-Associated Macrophages in Human Breast, Colorectal, Lung, Ovarian and Prostate Cancers.

Authors:  Irina Larionova; Gulnara Tuguzbaeva; Anastasia Ponomaryova; Marina Stakheyeva; Nadezhda Cherdyntseva; Valentin Pavlov; Evgeniy Choinzonov; Julia Kzhyshkowska
Journal:  Front Oncol       Date:  2020-10-22       Impact factor: 6.244

7.  Tumour-Targeted and Redox-Responsive Mesoporous Silica Nanoparticles for Controlled Release of Doxorubicin and an siRNA Against Metastatic Breast Cancer.

Authors:  Jialang Zhuang; Siqi Chen; Ye Hu; Fan Yang; Qin Huo; Ni Xie
Journal:  Int J Nanomedicine       Date:  2021-03-08

8.  Association of GSTP1 p.Ile105Val (rs1695, c.313A > G) Variant with the Risk of Breast Carcinoma among Egyptian Women.

Authors:  Magdy M Youssef; Afaf M Elsaid; Rasha A El-Saeed; Riyadh T Mukhlif; Hisham Megahed; Adel I Al-Alawy; Rami M Elshazli
Journal:  Biochem Genet       Date:  2021-05-03       Impact factor: 1.890

9.  Effect of hyaluronic acid on radiodermatitis in patients with breast cancer: a meta-analysis of randomized controlled trials.

Authors:  Chieh-Jui Lee; Hui-Fen Fang; Chin-Yun Wang; Kuei-Ru Chou; Tsai-Wei Huang
Journal:  Support Care Cancer       Date:  2022-01-20       Impact factor: 3.359

10.  Assessing Advantages and Drawbacks of Rapidly Generated Ultra-Large 3D Breast Cancer Spheroids: Studies with Chemotherapeutics and Nanoparticles.

Authors:  Austin R Holub; Anderson Huo; Kavil Patel; Vishal Thakore; Pranav Chhibber; Folarin Erogbogbo
Journal:  Int J Mol Sci       Date:  2020-06-21       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.